Taiko Pharmaceutical Co Ltd 4574.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 05/24/22 JST
643.00UNCH (UNCH)
52 week range
519.00 - 1,105.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close643.00
  • 52 Week High1,105.00
  • 52 Week High Date05/25/21
  • 52 Week Low519.00
  • 52 Week Low Date03/16/22

Key Stats

  • Market Cap214.16M
  • Shares Out43.32M
  • 10 Day Average Volume171,572.73
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-21.97

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close643.00
  • 52 Week High1,105.00
  • 52 Week High Date05/25/21
  • 52 Week Low519.00
  • 52 Week Low Date03/16/22
  • Market Cap214.16M
  • Shares Out43.32M
  • 10 Day Average Volume171,572.73
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-21.97

RATIOS/PROFITABILITY

  • EPS (TTM)-52.70
  • P/E (TTM)-12.20
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date12/29/2020
  • Div Amount8.00
  • Split Date-
  • Split Factor-

Latest On Taiko Pharmaceutical Co Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
TAIKO PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company. The Company is engaged in three business segments. The Pharmaceutical Product segment is engaged in the manufacturing, sales and export of gastrointestinal drugs under the name SEIROGAN, SEIROGAN TOI-A (sugar coated tablet) and PISHUT. The Infection Control segment is engaged in the planning, development and sales of infection control products, which apply proprietary technique regarding chlorine dioxide...
Hitoshi Shibata
Chairman of the Board, Representative Director
Takashi Shibata
President, Representative Director
Address
16F, ORIX Hommachi Bldg
1-4-1, Nishihon-machi
Nishi-ku
Osaka-shi, OSK
550-0005
Japan